9-cis-β-Carotene ase Inhibitor I G5 administration of all doses of

administration of all doses of Cariprazine (mean±SEM: 0

InChi: InChI=1S/C98H138N24O33/c1-5-52(4)82(96(153)122-39-15-23-70(122)92(149)114-60(30-34-79(134)135)85(142)111-59(29-33-78(132)133)86(143)116-64(43-55-24-26-56(123)27-25-55)89(146)118-67(97(154)155)40-51(2)3)119-87(144)61(31-35-80(136)137)112-84(141)58(28-32-77(130)131)113-88(145)63(42-54-18-10-7-11-19-54)117-90(147)66(45-81(138)139)110-76(129)50-107-83(140)65(44-71(100)124)109-75(128)49-106-73(126)47-104-72(125)46-105-74(127)48-108-91(148)68-21-13-38-121(68)95(152)62(20-12-36-103-98(101)102)115-93(150)69-22-14-37-120(69)94(151)57(99)41-53-16-8-6-9-17-53/h6-11

Epub 2012 May 5

HO-3867 inhibit cell migration/invasion and survival by inhibiting STAT3 phosphorylation

accounting for 32

9-cis-β-Carotene ase Inhibitor I G5 administration of all doses of9 cis Carotene, a precursor of retinal, is cleaved by beta carotene oxygenase 1 (BCMO1) to produce 9 cis retinal. 9 cis Carotene inhibits photoreceptor degeneration and restores retinal function in vivo. 9 cis Carotene has the potential for the study of congenital stationary night blindness and fundus albipunctatus. Product information CAS Number: 13312 52 2 Molecular Weight: 536. 87 Formula: C40H56 Chemical Name: 1,3,3 trimethyl 2